153 related articles for article (PubMed ID: 31724812)
21. 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients.
Verly IRN; van Kuilenburg ABP; Abeling NGGM; Goorden SMI; Fiocco M; Vaz FM; van Noesel MM; Zwaan CM; Kaspers GJL; Merks JHM; Caron HN; Tytgat GAM
Eur J Cancer; 2018 Feb; 90():102-110. PubMed ID: 29274926
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.
Eisenhofer G; Goldstein DS; Sullivan P; Csako G; Brouwers FM; Lai EW; Adams KT; Pacak K
J Clin Endocrinol Metab; 2005 Apr; 90(4):2068-75. PubMed ID: 15644397
[TBL] [Abstract][Full Text] [Related]
25. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated
Eisenhofer G; Prejbisz A; Peitzsch M; Pamporaki C; Masjkur J; Rogowski-Lehmann N; Langton K; Tsourdi E; Pęczkowska M; Fliedner S; Deutschbein T; Megerle F; Timmers HJLM; Sinnott R; Beuschlein F; Fassnacht M; Januszewicz A; Lenders JWM
Clin Chem; 2018 Nov; 64(11):1646-1656. PubMed ID: 30097498
[TBL] [Abstract][Full Text] [Related]
26. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
27. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
[TBL] [Abstract][Full Text] [Related]
28. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
Sadilkova K; Dugaw K; Benjamin D; Jack RM
Clin Chim Acta; 2013 Sep; 424():253-7. PubMed ID: 23830883
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract][Full Text] [Related]
30. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
31. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
Shen Y; Li H; Lu J; Luo X; Guan Q; Cheng L
Biomed Chromatogr; 2019 Jun; 33(6):e4484. PubMed ID: 30632178
[TBL] [Abstract][Full Text] [Related]
32. Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
Peitzsch M; Novos T; Kaden D; Kurlbaum M; van Herwaarden AE; Müller D; Adaway J; Grouzmann E; McWhinney B; Hoad K; Woollard G; Kema I; Boot C; Fassnacht M; Sweep F; Loh TP; Horvath AR; Eisenhofer G
Clin Chem; 2021 Aug; 67(8):1098-1112. PubMed ID: 33993248
[TBL] [Abstract][Full Text] [Related]
33. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
Berthold F; Hunneman DH; Harms D; Käser H; Zieschang J
Eur J Cancer; 1992; 28A(12):1950-4. PubMed ID: 1419287
[TBL] [Abstract][Full Text] [Related]
34. Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors.
Tohmola N; Itkonen O; Turpeinen U; Joenväärä S; Renkonen R; Hämäläinen E
Clin Chim Acta; 2015 Jun; 446():206-12. PubMed ID: 25896957
[TBL] [Abstract][Full Text] [Related]
35. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
[TBL] [Abstract][Full Text] [Related]
36. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
[TBL] [Abstract][Full Text] [Related]
37. [Biochemical diagnosis of pheochromocytoma and neuroblastomas].
Candito M; Billaud E; Chauffert M; Cottet-Emard JM; Desmoulin D; Garnier JP; Greffe J; Hirth C; Jacob N; Millot F; Nignan A; Patricot MC; Peyrin L; Plouin PF
Ann Biol Clin (Paris); 2002; 60(1):15-36. PubMed ID: 11830391
[TBL] [Abstract][Full Text] [Related]
38. Validation of an assay for quantification of free normetanephrine, metanephrine and methoxytyramine in plasma by high performance liquid chromatography with coulometric detection: Comparison of peak-area vs. peak-height measurements.
Nieć D; Kunicki PK
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():63-70. PubMed ID: 26310898
[TBL] [Abstract][Full Text] [Related]
39. [Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. 2. Clinical studies on urinary metanephrine and normetanephrine in patients with pheochromyocytoma and a patient with neuroblastoma].
Shimbo S
Naika Hokan; 1968 Sep; 15(9):299-310. PubMed ID: 5752086
[No Abstract] [Full Text] [Related]
40. Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
Harding M; Deyell RJ; Blydt-Hansen T
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1569. PubMed ID: 34612613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
